Alterity Therapeutics Limited
ATHE
$5.07
-$0.09-1.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.67% | 62.39% | -10.22% | -12.80% | -115.53% |
| Total Depreciation and Amortization | -11.52% | -12.81% | -1.66% | 0.41% | 38.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.10% | 31.57% | 137.25% | 142.76% | 353.92% |
| Change in Net Operating Assets | -67.13% | -67.74% | -223.88% | -226.78% | 195.34% |
| Cash from Operations | 62.95% | 63.64% | -85.96% | -90.30% | 20.86% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -232.43% | -232.43% | -24.45% | -24.45% | 237.89% |
| Issuance of Common Stock | 380.54% | 380.54% | -70.88% | -70.88% | 4,573.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -318.88% | -318.88% | 87.85% | 87.85% | -1,408.29% |
| Cash from Financing | 368.69% | 359.90% | -71.60% | -70.95% | 7,074.93% |
| Foreign Exchange rate Adjustments | -158.06% | -157.04% | -1,240.00% | -1,270.00% | -44.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8,639.37% | 8,474.50% | -134.60% | -140.06% | 103.28% |